Evidence map›Paper›PMID 36714581›Full record

SynthesisFrontiers in endocrinology2022

The clinical outcomes of imaging modalities for surgical management Cushing's disease - A systematic review and meta-analysis.

Chan Hee Koh, Danyal Z Khan, Ronneil Digpal, Hugo Layard Horsfall, Ahmad M S Ali, Stephanie E Baldeweg, Pierre-Marc Bouloux, Neil L Dorward, William M Drake, Jane Evanson and 4 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Chan Hee KohVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Danyal Z KhanVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Ronneil DigpalDepartment of Neurosurgery, University Hospital Southampton, Southampton, United Kingdom.
Hugo Layard HorsfallVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Ahmad M S AliDepartment of Neurosurgery, The Walton Centre, Liverpool, United Kingdom.
Stephanie E BaldewegDepartment of Diabetes and Endocrinology, University College Hospital, London, United Kingdom.
Pierre-Marc BoulouxCentre for Neuroendocrinology University College London Medical School, London, United Kingdom.
Neil L DorwardVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
William M DrakeCentre for Endocrinology, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
Jane EvansonDepartment of Radiology, Barts Health NHS Trust, London, United Kingdom.
Joan GrieveVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Danail StoyanovWellcome/EPSRC Centre for Interventional and Surgical Sciences, University College London, London, United Kingdom.
Márta KorbonitsCentre for Endocrinology, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
Hani J MarcusVictor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
University College London · GBNational Hospital for Neurology and Neurosurgery · GBQueen Mary University of London · GBBarts Health NHS Trust · GBUniversity College Hospital · GBUniversity Hospital Southampton NHS Foundation Trust · GBWalton Centre · GBWellcome / EPSRC Centre for Interventional and Surgical Sciences · GB

Funding

Cancer Research UKDepartment of HealthWellcome Trust
6 · The paper itself

Abstract

Introduction: Cushing's disease presents major diagnostic and management challenges. Although numerous preoperative and intraoperative imaging modalities have been deployed, it is unclear whether these investigations have improved surgical outcomes. Our objective was to investigate whether advances in imaging improved outcomes for Cushing's disease. Methods: Searches of PubMed and EMBASE were conducted. Studies reporting on imaging modalities and clinical outcomes after surgical management of Cushing's disease were included. Multilevel multivariable meta-regressions identified predictors of outcomes, adjusting for confounders and heterogeneity prior to investigating the effects of imaging. Results: 166 non-controlled single-arm studies were included, comprising 13181 patients over 44 years.The overall remission rate was 77.0% [CI: 74.9%-79.0%]. Cavernous sinus invasion (OR: 0.21 [CI: 0.07-0.66]; p=0.010), radiologically undetectable lesions (OR: 0.50 [CI: 0.37-0.69]; p<0.0001), previous surgery (OR=0.48 [CI: 0.28-0.81]; p=0.008), and lesions ≥10mm (OR: 0.63 [CI: 0.35-1.14]; p=0.12) were associated with lower remission. Less stringent thresholds for remission was associated with higher reported remission (OR: 1.37 [CI: 1.1-1.72]; p=0.007). After adjusting for this heterogeneity, no imaging modality showed significant differences in remission compared to standard preoperative MRI.The overall recurrence rate was 14.5% [CI: 12.1%-17.1%]. Lesion ≥10mm was associated with greater recurrence (OR: 1.83 [CI: 1.13-2.96]; p=0.015), as was greater duration of follow-up (OR: 1.53 (CI: 1.17-2.01); p=0.002). No imaging modality was associated with significant differences in recurrence.Despite significant improvements in detection rates over four decades, there were no significant changes in the reported remission or recurrence rates. Conclusion: A lack of controlled comparative studies makes it difficult to draw definitive conclusions. Within this limitation, the results suggest that despite improvements in radiological detection rates of Cushing's disease over the last four decades, there were no changes in clinical outcomes. Advances in imaging alone may be insufficient to improve surgical outcomes. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42020187751.

Indexed as

Pituitary ACTH HypersecretionRadiologyHumansMagnetic Resonance ImagingRadiographyTreatment Outcomeadvanced imagingcushingCushing’s diseaseimagingMRIPETpituitarytranssphenoidal

Identifiers

PMID36714581
PMCPMC9880448
OpenAlexW4316041101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.